Mar 22, 2017 8:00am EDT OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder
Mar 08, 2017 8:00am EST OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder
Mar 07, 2017 8:00am EST OPKO Subsidiary GenPath Women’s Health Announces the Availability of ClariTest™
Mar 03, 2017 8:00am EST OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
Feb 28, 2017 9:30am EST OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day
Feb 27, 2017 4:15pm EST OPKO Health to Announce 2016 Fourth Quarter Financial Results on March 1, 2017